AXS Stock Cash Flow Statements

AXIS Capital Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

AXIS Capital Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2016-03-31	2006-03-31	2005-12-31	2005-09-30	2005-06-30	2005-03-31	2004-09-30	2004-06-30	2004-03-31	2003-09-30

cash flows from operating activities:
net income	223,356,000	194,071,000	293,633,000	180,728,000	211,966,000	395,459,000	-142,578,000	188,097,000	150,676,000	180,097,000	48,491,000	-9,390,000	34,782,000	149,200,000	204,893,000	54,946,000	235,470,000	123,300,000	2,743,000	-65,384,000	120,044,000	-177,827,000	-754,000	38,399,000	177,047,000	108,781,000	48,386,000	204,816,000	143,525,440	-468,075,000	172,845,000	151,799,000	6,281,000	140,856,000	166,786,000	146,982,000
adjustments to reconcile net income to net cash from operating activities:
net investment (gains) losses	-42,375,000	30,005,000		-32,184,000	53,480,000	9,207,000	-23,041,000	53,113,000			42,558,000	146,460,000	173,263,000	94,508,000			-73,291,000	-29,645,000			-53,046,000	62,877,000	-42,711,000	-14,526,000	-21,229,000	-12,767,000
net realized and unrealized gains on other investments	-17,541,000	-22,410,000				-4,973,000				-486,000	-23,914,000	7,576,000	-13,776,000	-25,643,000									-10,767,000	-11,143,000	-31,600,000	-6,528,000	27,177,000
amortization of fixed maturities	-9,437,000	-10,621,000	-11,542,000	-8,496,000	-9,760,000	-8,630,000	-8,512,000	-5,739,000	-3,491,000	-2,425,000	1,220,000	5,035,000	8,987,000	10,896,000	7,238,000	9,547,000	11,089,000	7,965,000	8,495,000	9,548,000	8,491,000	6,359,000	4,883,000	5,024,000	2,760,000	5,832,000	19,100,000
interest in income of equity method investments	705,000	-2,291,000	-7,264,000				-1,328,000	-2,940,000	-2,100,000	2,205,000		7,560,000	-1,050,000	-11,550,000										-792,000	-2,634,000	-2,219,000
other amortization and depreciation	13,479,000	13,792,000	13,135,000	14,278,000	13,636,000	14,257,000	13,174,000	31,196,000	16,211,000	14,971,000	15,819,000	21,412,000	15,343,000	15,714,000	20,010,000	15,621,000	16,250,000	15,096,000	19,063,000	16,253,000	14,869,000	15,612,000	18,265,000	15,520,000	17,702,000	23,742,000	5,294,000
share-based compensation expense	11,260,000	11,829,000
changes in:
accrued interest receivable	138,000	5,503,000	11,668,000	-7,815,000	-10,883,000	-1,411,000	-5,829,000	617,000	-2,739,000	-3,826,000	-16,636,000	-4,181,000	-8,961,000	-654,000	-1,808,000	681,000	-1,825,000	3,585,000	5,305,000	-1,431,000	7,989,000	1,234,000	3,431,000	953,000	-3,788,000	1,544,000	2,616,000	1,182,000				6,126,000
reinsurance recoverable on unpaid losses and loss expenses	-2,141,184,000	-106,132,000	-44,352,000	-220,583,000	-91,716,000	-186,791,000	-288,462,000	-170,953,000	-41,091,000	6,675,000	-586,126,000	-243,969,000	-56,118,000	60,605,000
reinsurance recoverable on paid losses and loss expenses	-125,482,000	1,064,000	-82,910,000	-872,000	-18,344,000	98,362,000	-6,563,000	-21,597,000	21,028,000	-53,728,000	-100,038,000	70,307,000	100,981,000	30,441,000
deferred acquisition costs	-27,336,000	-103,121,000	50,528,000	18,447,000	-48,744,000	-94,737,000	54,162,000	81,461,000	-25,424,000	-88,700,000	69,446,000	33,319,000	-1,678,000	-111,635,000	79,573,000	30,297,000	2,873,000	-147,129,000	89,954,000	62,900,000	27,770,000	-119,796,000	94,580,000	70,944,000	45,713,000	-136,906,000	-175,038,000
prepaid reinsurance premiums	-46,193,000	-240,695,000	76,817,000	89,821,000	-53,592,000	-144,311,000	56,346,000	-207,059,000	-134,427,000	-80,592,000	45,737,000	56,618,000	-102,843,000	-176,010,000	81,436,000	17,329,000	-100,123,000	-184,288,000	83,502,000	73,364,000	-69,933,000	-181,055,000	140,184,000	50,686,000	-19,092,000	-260,567,000	-37,732,000
reserve for losses and loss expenses	366,801,000	278,614,000	-44,177,000	559,084,000	117,430,000	209,390,000	872,274,000	147,150,000	103,165,000	150,410,000	515,308,000	273,639,000	-61,768,000	-182,720,000	-3,935,000	512,178,000	131,938,000	97,161,000	268,186,000	471,360,000	90,461,000	348,285,000	251,342,000	237,532,000	-26,275,000	4,829,000		70,178,000		1,561,661,000	210,452,000	314,687,000	682,041,000	280,099,000	268,248,000	215,788,000
unearned premiums	289,020,000	653,052,000	-232,127,000	-221,032,000	324,052,000	611,974,000	-250,694,000	-138,622,000	315,312,000	462,751,000	-290,408,000	-302,858,000	144,303,000	736,045,000	-372,236,000	-232,760,000	147,577,000	867,277,000	-385,036,000	-349,367,000	22,699,000	774,703,000	-525,756,000	-351,842,000	-33,613,000	903,253,000	820,947,000	372,374,000	-358,299,341	-67,887,000	-11,304,000	437,606,000	34,057,000	27,678,000	476,937,000	152,071,000
insurance and reinsurance balances	-190,758,000	-326,816,000	196,437,000	194,362,000	-5,072,000	-267,456,000	117,402,000	278,235,000	-44,149,000	-337,675,000	10,223,000	329,186,000	89,306,000	-345,837,000	238,581,000	449,179,000	152,893,000	-491,151,000	239,211,000	273,980,000	61,749,000	-502,437,000	326,751,000	202,624,000	-21,300,000	-559,150,000	-737,185,000
other items	41,329,000	-66,765,000	21,540,000	32,276,000	47,838,000	-258,702,000	-69,699,000	100,307,000	-20,121,000	-56,368,000	28,084,000	-1,841,000	45,619,000	-117,710,000	81,532,000	76,447,000	5,399,000	-7,399,000	-7,971,000	-23,600,000	-25,080,000	-40,413,000	-58,401,000	17,185,000	-14,627,000	-38,536,000	-96,430,000
net cash from operating activities	-1,654,218,000	309,079,000	355,547,000	587,027,000	518,100,000	384,139,000	306,256,000	348,224,000	378,645,000	222,434,000	-224,794,000	403,244,000	380,455,000	133,311,000	104,658,000	475,237,000	389,781,000	145,146,000	-5,276,000	242,787,000	155,736,000	-49,744,000	-42,511,000	258,098,000	41,109,000	-57,692,000	-14,250,000	295,991,000	-1,147,133,310	287,892,000	415,559,000	445,302,000	478,254,000	419,024,000	365,476,000	374,489,000
cash flows from investing activities:
purchases of:
fixed maturities, available for sale	-1,889,661,000	-2,946,681,000	-3,265,735,000	-2,730,553,000	-2,083,380,000	-2,450,714,000	-1,182,307,000	-1,936,016,000	-1,616,425,000	-1,614,005,000	-2,010,093,000	-1,519,098,000	-1,659,312,000	-2,287,937,000	-1,950,268,000	-2,654,920,000	-2,856,598,000	-4,671,969,000
fixed maturities, held to maturity	-33,973,000	-9,950,000	-5,000,000	-23,722,000	-30,499,000	-46,534,000	-12,499,000	0	-4,999,000	-20,001,000	-7,748,000	-48,958,000	-147,912,000	-50,992,000	-50,625,000	-28,975,000	-56,426,000	-60,749,000
equity securities	-8,083,000	-73,063,000	-2,654,000	-33,734,000	-1,861,000	-76,270,000	-2,114,000	-3,116,000	-6,712,000	-77,560,000	-1,347,000	-43,053,000	-47,706,000	-2,218,000	-32,080,000	-38,724,000	-30,775,000	-35,668,000	-77,856,000	-24,303,000	408,000	-16,132,000	-12,936,000	-18,115,000	-3,468,000	-23,503,000	-102,963,000
mortgage loans	-10,153,000	-72,000	-14,577,000	-693,000	-833,000	-1,552,000	-2,549,000	-1,632,000	-6,656,000	-14,030,000	-3,045,000	-12,714,000	-58,462,000	-42,802,000	-60,630,000	-11,730,000	-27,974,000	-45,498,000	-83,969,000	-19,526,000	-11,026,000	-84,738,000	-64,309,000	-33,805,000	-80,941,000	-14,965,000	-61,263,000
other investments	-20,648,000	-20,729,000	-16,936,000	-14,601,000	-19,691,000	-18,368,000	-23,182,000	-10,704,000	-30,816,000	-26,308,000	-25,089,000	-18,899,000	-66,418,000	-37,311,000	-69,500,000	-68,678,000	-79,210,000	-46,324,000	-73,558,000	-17,241,000	-54,945,000	-20,858,000	-51,450,000	-25,203,000	-71,486,000	-70,039,000	-117,622,000
equity method investments	-2,385,000	-4,955,000	-2,018,000	-2,387,000	-3,211,000	-6,791,000	-10,894,000
short-term investments	-37,914,000	-196,153,000	-134,849,000	-92,228,000	-21,991,000	-82,199,000	-25,881,000	-145,566,000	-21,157,000	-54,895,000	-35,147,000	-51,391,000	-39,534,000	-50,896,000	-23,657,000	-18,800,000	-7,002,000	-109,597,000	-158,770,000	-71,578,000	-40,470,000	-94,352,000	-52,270,000	-26,024,000	-15,891,000	-85,045,000	-13,931,000
proceeds from the sale of:
proceeds from redemption of fixed maturities, available for sale	337,225,000	369,666,000	324,018,000	354,492,000	394,263,000	435,700,000	253,380,000	256,801,000	202,742,000	221,094,000
proceeds from redemption of fixed maturities, held to maturity	18,510,000	63,780,000	65,421,000	157,839,000	85,761,000	39,791,000	38,249,000	5,301,000	4,463,000	1,596,000
proceeds from redemption of short-term investments	15,795,000	102,524,000	15,699,000	12,900,000	35,901,000	4,510,000	30,473,000	3,502,000	32,050,000	10,520,000	0	2,094,000	12,500,000	5,530,000	39,752,000	30,797,000	18,982,000	21,886,000	11,759,000	0	56,173,000	1,775,000	3,572,000	8,223,000	5,158,000	2,413,000	2,282,000
proceeds from the repayment of mortgage loans	38,076,000	35,579,000	29,607,000	15,110,000	53,313,000	211,000	755,000	208,000	30,206,000	5,206,000	29,484,000	15,285,000	29,614,000	9,982,000	90,211,000	44,470,000	1,619,000	9,321,000	34,876,000	294,000	3,552,000	399,000	39,485,000	20,273,000	243,000	243,000
proceeds from the purchase of other asset	-12,069,000	-7,273,000
loan advances made	-25,465,000	-68,696,000	-22,579,000	-36,881,000	-38,356,000	-101,229,000	-199,963,000
net cash from investing activities	-184,507,000	462,286,000	1,390,982,000	-700,339,000	-621,230,000	211,039,000	-165,617,000	-544,111,000	13,522,000	-159,404,000	-422,057,000	-71,940,000	-484,418,000	322,617,000	-244,867,000	-522,646,000	-322,456,000	-24,226,000	103,947,000	-416,551,000	779,504,000	23,021,000	-1,472,000	-106,595,000	-563,478,000	-102,770,000	-14,839,000					40,036,000
cash flows from financing activities:
repurchase of common shares																											-136,011,000
taxes paid on withholding shares	-1,100,000	-24,514,000	-982,000	-387,000	-435,000	-14,121,000	-6,172,000	-373,000	-1,106,000	-15,945,000	-306,000	-342,000	-369,000	-12,977,000	-216,000	-206,000	-439,000	-9,381,000	-1,697,000	-83,000	-111,000	-8,491,000	-720,000	-31,000	-411,000	-9,003,000
dividends paid - common shares	-34,772,000	-39,590,000	-37,135,000	-37,121,000	-37,301,000	-40,208,000	-38,206,000	-37,547,000	-37,699,000	-40,323,000	-36,453,000	-36,441,000	-36,704,000	-39,743,000	-35,629,000	-35,668,000	-35,723,000	-38,583,000	-34,995,000	-34,601,000	-34,676,000	-37,318,000	-33,683,000	-33,578,000	-33,688,000	-36,260,000	-36,636,000
dividends paid - preferred shares	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-7,563,000	-7,562,000	-9,144,000	-10,656,000	-10,656,000	-10,657,000	-10,656,000	-10,003,000
net cash from financing activities	-93,423,000	-511,659,000	-114,937,000	-95,199,000	-83,659,000	-123,499,000	-51,940,000	-45,483,000	-46,367,000	-58,581,000	-44,321,000	34,604,000	-79,622,000	-60,283,000	-43,407,000	-43,437,000	-43,724,000	-55,527,000	-44,254,000	-42,247,000	-542,349,000	-279,953,000	376,116,000	-44,265,000	1,578,000	-55,919,000	-183,710,000									317,348,000
effect of exchange rate changes on foreign currency cash, cash equivalents and restricted cash	8,582,000	9,440,000	-39,297,000	24,774,000	278,000	-14,090,000	27,971,000	-9,585,000	-6,825,000	193,000	30,563,000	-28,574,000	-25,198,000	-6,624,000	2,102,000	607,000	5,563,000	-8,346,000	7,999,000	7,994,000	14,879,000	-28,718,000
increase in cash, cash equivalents and restricted cash	-1,923,566,000	269,146,000	1,592,295,000	-183,737,000	-186,511,000	457,589,000	116,670,000	-250,955,000	338,975,000	4,642,000		337,334,000	-208,783,000	389,021,000			29,164,000	57,047,000
cash, cash equivalents and restricted cash - beginning of period	0	3,063,621,000		0	0	1,383,985,000		0	0	1,174,653,000		0	0	1,317,690,000		0	0	1,503,232,000		0	0	1,576,457,000
cash, cash equivalents and restricted cash - end of period	-1,923,566,000	3,332,767,000		-183,737,000	-186,511,000	1,841,574,000		-250,955,000	338,975,000	1,179,295,000		337,334,000	-208,783,000	1,706,711,000		-90,239,000	29,164,000	1,560,279,000		-208,017,000	407,770,000	1,241,063,000
repurchase of common shares - open market		-439,992,000	-60,058,000	-39,918,000	-38,361,000	-61,607,000					0	0
net investment losses										20,190,000
share-based compensation expense, net of cash payments			9,257,000	10,199,000	9,605,000	13,670,000	14,209,000	15,271,000	15,705,000	8,935,000	12,397,000	14,371,000	14,065,000	7,661,000	11,896,000	11,898,000	12,229,000	1,721,000	11,355,000	10,525,000	11,775,000	-4,650,000	11,331,000	12,060,000	12,779,000	-3,679,000	-1,357,000
unsettled payable for reverse repurchase agreements included in cash and cash equivalents
proceeds from the purchase of other assets
federal home loan bank advances			-9,200,000				0	0	0	5,250,000	0
cash, cash equivalents and restricted cash - beginning of year
cash, cash equivalents and restricted cash - end of year
in 2024, net investment losses in the consolidated statement of cash flows included net realized gains on overseas deposits of 6 million that are included in net investment gains in the consolidated statement of operations.
net realized and unrealized (gains) losses on other investments				-19,566,000				-313,000								-40,117,000	-41,414,000	-41,833,000		-25,126,000	37,581,000	2,119,000
proceeds from the (purchase) sale of other asset				-5,014,000
interest in (income) loss of equity method investments					-7,900,000	-1,169,000									-1,213,000	-11,911,000	-9,798,000	-9,162,000	-9,967,000	-2,896,000	-7,102,000	23,577,000
proceeds from the (purchase) sale of other assets						-8,208,000	-14,925,000	-8,635,000
amortization of value of business acquired															771,000	1,027,000	1,028,000	1,028,000	1,028,000	1,028,000	1,284,000	1,799,000	2,056,000	4,368,000	7,194,000	13,104,000
supplemental disclosures of cash flow information:
income taxes paid								23,209,000	33,950,000	-2,403,000						13,699,000	20,868,000	8,981,000		-4,901,000	1,723,000	-2,131,000		-1,256,000	12,084,000	1,321,000		8,276,000	-23,836,200	1,309,000
interest paid								17,607,000	14,490,000	17,110,000						16,263,000	7,000,000	22,700,000		12,288,000	21,687,000	13,133,000		6,437,000					-15,646,949	0
proceeds from the sale (purchase) of other assets										5,299,000
purchase of other assets											-11,788,000	-7,994,000	-6,616,000	-10,431,000	-8,026,000	-16,599,000	-7,891,000	-6,216,000	-8,079,000	-8,112,000	-14,985,000	-13,485,000	-21,306,000	-9,053,000	-20,696,000	-12,051,000	-44,721,000
redemption of senior notes																			0	0				0
repurchase of preferred shares																			0	0	0	-225,000,000					-2,843,000
decrease in cash, cash equivalents and restricted cash															-181,514,000							-335,394,000
proceeds from the redemption of fixed maturities, available for sale												180,498,000	253,618,000	416,838,000		420,931,000	474,535,000	486,401,000
proceeds from the redemption of fixed maturities, held to maturity												0	0	3,500,000		15,450,000	57,727,000	61,170,000
net investment gains															-20,411,000
non-cash foreign exchange gains
net proceeds from issuance of senior notes																								0
reinsurance recoverable balances on unpaid and paid losses																-408,193,000	-100,514,000	-61,380,000		-152,759,000	-93,815,000	-260,131,000		-18,894,000	-47,928,000	-98,425,000
reinsurance recoverable on unpaid and paid losses and loss expenses
fixed maturities																			-1,950,557,000	-3,232,378,000	-2,534,210,000	-2,777,053,000	-2,288,354,000	-2,690,946,000	-2,589,639,000	-2,425,086,000	-2,556,709,000
proceeds from redemption of fixed maturities																			370,748,000	359,054,000	372,387,000	424,207,000	397,668,000	315,206,000	291,772,000	278,150,000	246,147,000
non-cash foreign exchange losses
bargain purchase gain
purchase of subsidiaries
net proceeds from issuance of debt
repayment of notes payable
effect of exchange rate changes on foreign currency cash, cash equivalents, and restricted cash																								6,599,000	9,247,000	-7,381,000
increase in cash, cash equivalents, and restricted cash																								113,837,000	-511,544,000	-223,762,000
cash, cash equivalents, and restricted cash - beginning of period																								0	0	1,830,020,000
cash, cash equivalents, and restricted cash - end of period																								113,837,000	-511,544,000	1,606,258,000
reserve for loss and loss expenses																											50,132,000
net proceeds from issuance of preferred shares
proceeds from issuance of common shares																											1,783,000
reinsurance recoverable balances																											-6,668,000	108,044,000
purchase of subsidiary
interest in loss of equity method investments
net realized investment (gains) losses
change in restricted cash and cash equivalents																											11,627,000
net realized investment losses																											66,508,000
effect of exchange rate changes on foreign currency cash and cash equivalents																											1,986,000
increase in cash and cash equivalents																											-210,813,000	230,629,000		68,880,000	47,239,000	113,736,000	214,116,000	-80,914,000	196,954,000
cash and cash equivalents - beginning of period																											988,133,000						0	0	605,175,000	0
cash and cash equivalents - end of period																											777,320,000				47,239,000	746,065,000	214,116,000	-80,914,000	802,129,000	-136,483,000
purchase of subsidiary, net of cash acquired
decrease in cash and cash equivalents
sales of shares to noncontrolling interests
return of capital to noncontrolling interests
impact of the deconsolidation of a variable interest entity
cash and cash equivalents - beginning of year
cash and cash equivalents - end of year
net realized investment gains
sale of shares to noncontrolling interests
net realized and unrealized gains of other investments
effect of exchange rate changes on foreign currency cash
non-cash financing activities:
repurchase of series a preferred shares included in other liabilities
repurchase of class a preferred shares included in other liabilities
loss on insurance derivative contract
settlement of insurance derivative contract
repurchase of shares
net realized and unrealized (gains) losses of other investments
net sales (purchases) of short-term investments
net (purchases) sales of short-term investments
net purchases (sales) of short-term investments
amortization/(accretion) of fixed maturities
proceeds from the redemption of fixed maturities
repayment of repurchase agreement
unrealized loss on insurance derivative contract
amortization/accretion of fixed maturities
net sales of short-term investments
net cash from by financing activities
(decrease) in cash and cash equivalents
net realized and unrealized losses (gains) of other investments
purchases of fixed maturities
sales and maturities of fixed maturities
purchases of other investments
sales of other investments
purchase of equity securities
sale of equity securities
purchase of assets
(repayment) proceeds from repurchase agreement
proceeds from issuance of stock options
proceeds from issuance of preferred shares
net unrealized losses (gains) of other investments
purchases of equity securities
sales of equity securities
purchases of assets
proceeds from exercise of stock options
other
change in fair value of other investments
purchases of available-for-sale fixed maturities
sales and maturities of available-for-sale fixed maturities
net change in fair value of other investments
amortization/accretion of fixed maturity investments
purchase of available-for-sale securities
sales and maturities of available-for-sale securities																												1,172,473,000	-4,371,153,577	1,402,998,000	1,638,197,000	1,336,399,000
issuance of common shares
(decrease)/increase in cash and cash equivalents
dividends paid — common shares
dividends paid — preferred shares
cash and cash equivalents — beginning of period																												1,280,990,000
cash and cash equivalents — end of period																												1,511,619,000
change in carrying value of other investments
acquisitions, net of cash acquired
dividends paid—common shares
dividends paid—preferred shares
proceeds from issuance of senior notes
proceeds from repurchase agreement
issuance of preferred shares
cash and cash equivalents—beginning of period
cash and cash equivalents—end of period
net realized losses (gains) on sales of investments
net amortization on fixed maturities and other investments
amortization of deferred compensation and option expense																												6,100,000	-17,958,447	5,689,000	6,225,000	6,070,000
amortization of intangible assets																												957,000	-2,739,322	1,976,000	385,000	382,000	383,000	420,000	375,000	375,000
amortization of deferred debt expenses																												113,000	-339,547	112,000	65,000	163,000
insurance and reinsurance premium balances receivable
reinsurance recoverable balances on paid losses
insurance and reinsurance balances payable																													-77,917,708	74,171,000	-35,341,000	39,154,000	-17,946,000	14,889,000	41,871,000	-39,907,000
accounts payable and accrued expenses																																3,182,000				5,668,000
total adjustments																												91,175,000	-1,290,658,750	755,967,000	242,714,000	293,503,000	471,973,000	278,168,000	198,690,000	227,507,000
acquisition of subsidiaries, net of cash accrued
purchases of available-for-sale securities
common share dividends
preferred shares dividends
issuance of shares
net amortization on fixed maturities																												7,518,000		8,865,000	7,387,000	7,511,000
other assets
purchases of available—for—sale securities
sales and maturities of available—for—sale securities
net realized losses on sales of investments																												8,114,000
net cash from provided by investing activities
preferred share dividends
issue of common shares																												13,160,000
amortization/accretion on fixed maturities
intangible assets																														-1,020,000	515,000	505,000
net cash paid in acquisition of subsidiaries
common share dividends paid
proceeds received from issuance of senior notes
issue of preferred shares
increase/(decrease) in cash and cash equivalents																																				-136,483,000
net realized gain on sales of investments
issue of shares																														246,107,000	519,000	37,000			60,000	317,348,000
net realized gains on sales of investments																																1,393,000
dividend
cash and cash equivalents – beginning of period																															0	632,329,000
amortization of discounts on fixed maturities																																	8,265,000	9,058,000	8,589,000	6,723,000
amortization of deferred compensation																																	4,134,000	4,621,000	4,636,000	2,048,000
reinsurance recoverable
sales of available-for-sale securities																																	1,455,666,000	1,386,275,000	1,372,134,000	3,752,566,000

We provide you with 20 years of cash flow statements for AXIS Capital stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of AXIS Capital stock. Explore the full financial landscape of AXIS Capital stock with our expertly curated income statements.

The information provided in this report about AXIS Capital stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.